Immediate Impact
68 standout
Citing Papers
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
Understanding and targeting resistance mechanisms in cancer
2023 Standout
Works of Marit Scheistrøen being referenced
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin
2003
Hexamethylmelamine as second-line therapy in platin-resistant ovarian cancer
1992
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Marit Scheistrøen | 159 | 146 | 160 | 15 | 380 | |
| E.J. Aartsen | 78 | 164 | 130 | 13 | 380 | |
| Garron J. Solomon | 55 | 76 | 99 | 15 | 360 | |
| Tsutomu Yuminamochi | 168 | 173 | 69 | 22 | 447 | |
| J.T. Soper | 81 | 97 | 162 | 14 | 412 | |
| LiVolsi Va | 66 | 95 | 145 | 19 | 406 | |
| Vaidehi Kannan | 146 | 130 | 83 | 15 | 347 | |
| Meagan Judge | 67 | 103 | 113 | 17 | 381 | |
| B. Bolger | 184 | 102 | 84 | 11 | 361 | |
| Sakiko Kojiro | 115 | 88 | 126 | 16 | 346 | |
| Yan Gao Man | 53 | 42 | 124 | 13 | 375 |
All Works
Loading papers...